Use

The HPV Primary Screen by PCR With Reflex to Cytology is an FDA-approved test for routine cervical cancer screening in individuals aged 25 years and older with a cervix. This test detects DNA from high-risk HPV types, including HPV16, HPV18, and 12 other types associated with cervical cancer and its precursor lesions. Positive results for high-risk HPV types prompt reflex testing with cytology, and positive cases for HPV 16 or 18 should be managed according to current clinical guidelines, specifically the ASCCP guidelines from 2019.